Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defining high-risk prostate cancer: current status.

The Canadian journal of urology - 1 Feb 2005

Fleshner Neil

Abstract excerpt

Defining men at high risk for prostate cancer treatment failure and death continues to evolve. Identifying these men allows for better disease prognostication, patient decision treatment making and facilitates accrual for appropriate clinical trials. Men at traditional high risk for prostate cancer progression and death include men with advanced clinical stage, higher levels of PSA and Gleason pattern 4....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to Androgens
Share to Biopsy, Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ontario

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Socioeconomic Factors

Share to Survival Analysis

Source

Identifiers

PMID: 15780159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defining high-risk prostate cancer: current status.PMID 15780159Read ↗

Prostate cancer – a biomarker perspectiveSemantic proximity Read ↗

Prostate cancer: A step to identifying men at high risk of metastatic disease.Semantic proximity Read ↗

Precision intervention for prostate cancer: Re-evaluating who is at risk.Semantic proximity Read ↗

Genetics and Screening in Prostate Cancer.Semantic proximity Read ↗

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerSemantic proximity Read ↗

Genetic testing for the clinician in prostate cancer.Semantic proximity Read ↗

Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.Semantic proximity Read ↗

Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.Semantic proximity Read ↗

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsSemantic proximity Read ↗

Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.Semantic proximity Read ↗

New Strategies in Prostate Cancer: Translating Genomics into the ClinicSemantic proximity Read ↗

Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.